Literature DB >> 28655527

Changes in Adenosine Triphosphate and Nitric Oxide in the Urothelium of Patients with Benign Prostatic Hyperplasia and Detrusor Underactivity.

Kang Jun Cho1, Jun Sung Koh1, Jinbong Choi1, Joon Chul Kim2.   

Abstract

PURPOSE: We investigated changes in the levels of adenosine triphosphate and nitric oxide in the urothelium of men with detrusor underactivity and benign prostatic hyperplasia.
MATERIALS AND METHODS: We prospectively enrolled in study 30 men who planned to undergo surgical treatment for benign prostatic hyperplasia. The 15 patients with a bladder contractility index less than 100 were assigned to the detrusor underactivity group while the 15 with a bladder contractility index more than 100 were assigned to the no detrusor underactivity group. Bladder mucosal specimens were collected at surgical prostate resection, and adenosine triphosphate and endothelial nitric oxide synthase were analyzed in these specimens. The levels of adenosine triphosphate and endothelial nitric oxide synthase were compared between the 2 groups. The correlation of urodynamic parameters with adenosine triphosphate and endothelial nitric oxide synthase was assessed in all patients.
RESULTS: Mean ± SEM endothelial nitric oxide synthase did not significantly differ between the detrusor underactivity and no underactivity groups (3.393 ± 0.969 vs 1.941 ± 0.377 IU/ml, p = 0.247). However, the mean level of adenosine triphosphate in the detrusor underactivity group was significantly lower than in the no detrusor underactivity group (1.289 ± 0.320 vs 9.262 ± 3.285 pmol, p = 0.011). In addition, in all patients adenosine triphosphate positively correlated with the bladder contractility index (r = 0.478, p = 0.018) and with detrusor pressure on maximal flow (r = 0.411, p = 0.046).
CONCLUSIONS: Adenosine triphosphate was significantly decreased in the urothelium in men with detrusor underactivity and benign prostatic hyperplasia, reflecting the change in detrusor function.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adenosine triphosphate; bladder; nitric oxide; prostatic hyperplasia; urinary tract symptoms

Mesh:

Substances:

Year:  2017        PMID: 28655527     DOI: 10.1016/j.juro.2017.06.080

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Underactive bladder: A review of the current treatment concepts.

Authors:  Ömer Bayrak; Roger Roman Dmochowski
Journal:  Turk J Urol       Date:  2019-02-04

2.  Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction.

Authors:  Kang Jun Cho; Jun Sung Koh; Jin Bong Choi; Sang Hi Park; Weon Sun Lee; Joon Chul Kim
Journal:  Investig Clin Urol       Date:  2022-03-23

Review 3.  New therapeutic directions to treat underactive bladder.

Authors:  Toby C Chai; Tambudzai Kudze
Journal:  Investig Clin Urol       Date:  2017-12-19

4.  DU Is Induced by Low Levels of Urinary ATP in a Rat Model of Partial Bladder Outlet Obstruction: The Incidence of Both Events Decreases after Deobstruction.

Authors:  Luís Vale; Ana Charrua; Helena Cavaleiro; Rita Ribeiro-Oliveira; António Avelino; Tiago Antunes-Lopes; António Albino-Teixeira; Francisco Cruz
Journal:  Adv Urol       Date:  2022-02-28

5.  Correlation Between Nitric Oxide and Urodynamics in Men With Bladder Outlet Obstruction.

Authors:  Kang Jun Cho; Jun Sung Koh; Jin Bong Choi; Sang Hi Park; Weon Sun Lee; Joon Chul Kim
Journal:  Int Neurourol J       Date:  2021-05-06       Impact factor: 2.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.